Ticker Details
Organogenesis Holdings Inc.
IPO Date:	January 2, 2017
Sector:	Healthcare
Industry:	Drug Manufacturers - Specialty and Generic
Market Cap:	$231.61M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.31 | 4.19%
Avg Daily Range (30 D):	$0.10 | 4.66%
Avg Daily Range (90 D):	$0.08 | 3.48%

Institutional Daily Volume
Avg Daily Volume:	.66M
Avg Daily Volume (30 D):	.72M
Avg Daily Volume (90 D):	.84M

Trade Size
Avg Trade Size (Sh.):	120
Avg Trade Size (Sh.) (30 D):	116
Avg Trade Size (Sh.) (90 D):	127

Institutional Trades
Total Institutional Trades:	929
Avg Institutional Trade:	$2.31M
Avg Institutional Trade (30 D):	$1.13M
Avg Institutional Trade (90 D):	$1.6M
Avg Institutional Trade Volume:	.37M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.04M
Avg Closing Trade (30 D):	$2.72M
Avg Closing Trade (90 D):	$1.75M
Avg Closing Volume:	259.58K

News

Apr 24, 2026 @ 7:54 AM Tissue Engineering Market to Grow at 12.95% CAGR R... Source: Mordor Intelligence

Apr 6, 2026 @ 11:02 PM Organogenesis Achieves Primary Endpoint in Randomi... Source: Na

Feb 3, 2026 @ 6:59 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Pomerantz Llp

Dec 30, 2025 @ 9:38 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Pomerantz Llp

Nov 20, 2025 @ 6:00 PM Global Wound Healing Devices Market Poised for Rob... Source: Delveinsight

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.82	$-.77	$-.44
Diluted EPS	$-.83	$-.77	$-.44
Revenue	$457.45M	$43.76M	$37.23M
Gross Profit
Net Income / Loss	$-84.16M	$-96.27M	$-53.16M
Operating Income / Loss	$-35.87M	$-50.99M	$-68.89M
Cost of Revenue
Net Cash Flow	$-26.89M	$-45.26M	$-2.23M
PE Ratio